Ep. 148 GLP-1 & Longevity in Midlife: Why I'll Never Stop Taking It
If you've been told GLP-1s are just for weight loss, or you're on one and wondering if it's actually doing anything beyond the scale, this episode is going to shift how you think about these medications entirely.
Because weight loss is the least interesting thing they do.
GLP-1 medications were originally developed for type 2 diabetes back in 2005. Weight loss didn't even enter the picture until 2021. And in the years since, researchers have been uncovering benefits that go way beyond appetite suppression, benefits that are especially relevant for women navigating perimenopause and menopause.
In this episode, I walk through all of it. The research. The data. And why I personally consider this part of my longevity plan.
In This Episode, You'll Learn:
Why GLP-1s were never actually designed for weight loss and what they were designed for
How estrogen decline changes your metabolic health risks in midlife
What the SELECT trial found about GLP-1s and cardiovascular disease and why it matters for women
The blood sugar connection and why prediabetes risk goes up in perimenopause
What the research shows about GLP-1s and kidney disease, sleep apnea, and fatty liver disease
Where the science is headed next and why researchers can't stop studying these medications
Resources Mentioned:
Grab my free Menopause Peptide Guide: https://cindistickle.myflodesk.com/menopausepeptideguidepodcast
Book a Metabolism Consultation: https://cal.com/cindi-stickle/metabolism-consultation
Connect with Cindi:
Follow on Instagram: http://instagram.com/cindisticklenutrition
Read the blog: https://cindistickle.com/blog
Come hang out in the Facebook Group: https://www.facebook.com/groups/nobsmenopause
